Bellows S ⚠ 동명이인 가능성

제1저자 또는 공저자로 매칭된 논문 · word-boundary on `authors` column

이름 + 이니셜 1자만으로는 동명이인 구분이 어렵습니다. 상세 비교는 Bellows S 비교 뷰 →

5 논문
2 최근 5년
2 최근 1년
2019–2025 활동기

주요 저널

  • Toxins 3
  • Parkinsonism & related disorders 1
  • Clinical parkinsonism & related disorders 1

주요 공저자 Top 10

  1. Jankovic J 4편
  2. Martino D 1편
  3. Ramezani M 1편
  4. Berman BD 1편
  5. Chang FC 1편
  6. Feuerstein J 1편
  7. Fung V 1편
  8. Berkmen GK 1편
  9. Malaty IA 1편
  10. MacIver C 1편

연도별 분포

  • 2025 2
  • 2020 2
  • 2019 1

최근 발표

공저자 네트워크

중심 = Bellows S · 공저 횟수 상위 30
공저자 엣지
본인 공저자 본인-공저자 공저자 사이
⏳ 그래프 로딩 중…

노드 더블클릭 = 해당 저자 페이지로 이동 · 호버 = 공저 횟수 툴팁

논문 목록

5건 · 최신순
  • Diagnostic accuracy of screening tools for depression and anxiety in cervical dystonia.
    Parkinsonism & related disorders 2025 Martino D 외 PMID: 40446700

    [INTRODUCTION] Despite their high prevalence and impact, depression and anxiety are not routinely screened for, and accuracy of screening procedures is unknown in adult-onset dystonia. We evaluated accuracy parameters of selected self-rated…

  • Botulinum Toxin for the Treatment of Tremors.
    Toxins 2025 Bellows S (제1저자) PMID: 40864077

    Tremor, an oscillatory movement disorder, is commonly encountered in clinical practice in the setting of a variety of etiologies, such as essential tremor and Parkinson's disease. Despite its high prevalence, treatment options are somewhat …

  • Treatment of dystonia and tics.
    Clinical parkinsonism & related disorders 2020 Bellows S (제1저자) PMID: 34316614

    Treatment of dystonia and tics continues to evolve. In dystonia, while oral agents such as benzodiazepines, baclofen and anticholinergics remain in use, botulinum toxin (BoNT) continues to be regarded as the treatment of choice for focal an…

  • Reply to Comment on Re-Visiting Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491.
    Toxins 2020 Bellows S (제1저자) PMID: 31979241

    We appreciate the commentary on our article by Foster and Beard, both employees of Ipsen [...].…

  • Immunogenicity Associated with Botulinum Toxin Treatment.
    Toxins 2019 Bellows S (제1저자) PMID: 31454941

    Botulinum toxin (BoNT) has been used for the treatment of a variety of neurologic, medical and cosmetic conditions. Two serotypes, type A (BoNT-A) and type B (BoNT-B), are currently in clinical use. While considered safe and effective, thei…